Which of the following statements accurately differentiates dexmethylphenidate from MPH?
A. It is more effective for inattention but less effective for hyperactivity. B. It is twice as potent as MPH, with a maximum daily dose of 20 mg/day. C. A once-daily preparation is not available for dexmethylphenidate, whereas there are 3 once-daily MPH preparations. D. It has less abuse potential. • Which of the following statements is accurate regarding guanfacine in the treatment of ADHD? A. An extended-release preparation is under investigation for the treatment of ADHD. B. It is associated with more sedation and constipation than clonidine. C. It has a shorter half-life, compared with clonidine. D. Reports of panic attacks have been described. • Describe the role of atypical antipsychotics in the treatment of ADHD. A. They are an alternative to stimulant in patients with ADHD and Tourette’s syndrome. B. They should be used short term to control aggression and violent behavior. C. They can replace stimulant if the patient is at risk of substance abuse. D. They are an adjunct to st
